BridgeMD
Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis
EU CTIS ID: 2024-515781-13-00
What this study is testing
Estimation of diagnostic accuracy of 68Ga citrate PET / CT in the diagnosis of chronic hip or knee joint prosthesis infection
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients aged over 18 years old
- Patient with first complete care at the South-Western France referral center for complex bone and joint infections (Crioac GSO, infectious diseases and orthopedic surgery units) for a suspicion of prosthetic hip or knee infection
- Suspicion of artificial joint infection starting at least one month before evaluation.
- Patient for who routine diagnosis includes screaning by both bone scintigraphy and polynuclear scintigraphy.
- Patient with positive bone scintigraphy
- Being affiliated to a health insurance system
You likely can't join if
- Patient with progressive cancer
- Patient with negative bone scintigraphy
- Patient who cannot stop antibiotic for 14 days because of his state of health
- Pregnant or breastfeeding women
- Women of childbearing age but not using effective means of contraception
- Patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent)
See the full eligibility criteria
- Patients aged over 18 years old
- Patient with first complete care at the South-Western France referral center for complex bone and joint infections (Crioac GSO, infectious diseases and orthopedic surgery units) for a suspicion of prosthetic hip or knee infection
- Suspicion of artificial joint infection starting at least one month before evaluation.
- Patient for who routine diagnosis includes screaning by both bone scintigraphy and polynuclear scintigraphy.
- Patient with positive bone scintigraphy
- Being affiliated to a health insurance system
- Having signed an informed consent form (later than the day of inclusion and before any examination required by the research)
- Patient with progressive cancer
- Patient with negative bone scintigraphy
- Patient who cannot stop antibiotic for 14 days because of his state of health
- Pregnant or breastfeeding women
- Women of childbearing age but not using effective means of contraception
- Patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent)
- Subject in relative exclusion period from another protocol
- Known contraindications to PET exam with radio tracer injection (hypersensitivity to radiopharmaceutical and/or to excipients)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.